NDC 0061-0089 - Posatex
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-0089
- Package NDCs from labels
- 0061-0089-01, 0061-0089-02, 0061-0089-03
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2024-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Posatex - Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp. | 2024-10-29 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-0089-01 | Posatex | 1 in 1 CARTON | SUSPENSION | 1 | 9 | |
| 0061-0089-01 | Posatex | 7.5 g in 1 BOTTLE, PLASTIC | SUSPENSION | 7.5 | 9 | |
| 0061-0089-02 | Posatex | 1 in 1 CARTON | SUSPENSION | 1 | 9 | |
| 0061-0089-02 | Posatex | 15 g in 1 BOTTLE, PLASTIC | SUSPENSION | 15 | 9 | |
| 0061-0089-03 | Posatex | 30 g in 1 BOTTLE, PLASTIC | SUSPENSION | 30 | 9 | |
| 0061-0089-03 | Posatex | 1 in 1 CARTON | SUSPENSION | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mometasone Furoate | MOMETASONE FUROATE | A-S Medication Solutions | 9fe65193-b4d8-480b-89b3-178cd1b20713 | 2023-02-15 | Warnings, Adverse reactions | 04201GDN4R |
| Sinuva | MOMETASONE FUROATE | Intersect ENT, Inc. | e33c1b23-cdc6-4f64-94ba-24b0b42c09bf | 2023-01-26 | Warnings, Adverse reactions | 04201GDN4R |
| POSACONAZOLE | POSACONAZOLE DELAYED-RELEASE | Chartwell RX, LLC | f2baa339-75ff-4c03-8334-a88648f701f7 | 2022-12-20 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Posaconazole | POSACONAZOLE | Camber Pharmaceuticals, Inc. | 573d89eb-05d8-4035-b406-6409f36ab707 | 2022-12-17 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Posaconazole | POSACONAZOLE | NorthStar RxLLC | 4de6d839-e4bd-405c-83c5-8efc6abd0829 | 2022-12-17 | Warnings, Adverse reactions | 6TK1G07BHZ |
| POSACONAZOLE | POSACONAZOLE | Biocon Phama Inc. | e0e8023a-3c82-e455-a57b-ccc0206ad156 | 2022-04-27 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Mometasone Furoate | MOMETASONE FUROATE | Proficient Rx LP | 47a60763-671e-413b-b962-f7f11ba2f4d7 | 2021-01-01 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Glenmark Pharmaceuticals Inc., USA | 96eafc06-0354-49ca-a684-a77bb2afc8f5 | 2020-05-31 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Proficient Rx LP | c08fcb0d-7fff-4d90-aeb8-e912b930bf3d | 2020-02-01 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Glenmark Pharmaceuticals Inc., USA | 031283ed-988b-4698-8a2e-00f3d41c0f71 | 2019-07-09 | Warnings, Adverse reactions | 04201GDN4R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.